References
- BORENFREUND, E. and PUERNER, J., 1985, Toxicity determined in vitro by morphological alteration and neutral red absorption. Toxicology Letters, 24, 119–224.
- DE ANGELIS I., HOOGENBOOM, L. A. P., HUVENEERS -0ORSPRONG, M. B. M., Zucco, F. and STAMMATI A., 1994, Established cell lines for safety assessment of food contaminants: differing furazolidone toxicity to V79, HEp-2 and Caco-2 cells. Food and Chemical Toxicology, 32, 481–488.
- DELIE, F. and RUBAS, W., 1997, A human colonic cell line sharing similarities with enterocytes as a model to examine oral absorption: advantages and limitations of the Caco-2 model. Critical Reviews in Therapeutic Drug Carrier Systems, 14, 221–286.
- FISHER, R. B. and GARDNER, M. L. G., 1974, A kinetic approach to the study of solutes by isolated perfused small intestine. Journal of Physiology, 241, 211–234.
- FOGH, J., FOGH, J. M. and ORFEO, T., 1977, One hundred and twenty seven cultured human tumor cell lines producing tumors in nude mice. Journal of the National Cancer Institute, 59, 221–226.
- GRASSET, E., PINTO, M., DUSSAULX, E., ZWEIBAUM, A. and DESJEUX, J. F., 1984, Epithelial properties of human colonic carcinoma cell line Caco-2 : electrical parameters. American Journal of Physiology, 247, C260–267.
- GRASSET, E., BERNAREU, J. and PINTO, M., 1985. Epithelial properties of human colonic carcinoma cell line (Caco-2): effect of secretagogues. American Journal of Physiology, 248, C410-418. GUENGERICH, F. P., 1989, Analysis and characterisation of enzymes. In W. Hayes (ed.), Principles and Methods of Toxicology (New York: Raven), pp. 784–785.
- HOOGENBOOM, L. A. P., VAN KAMMEN M., BERGHMANS, M. C. J., KOEMAN, J. H. and KUIPER, H. A., 1991, The use of pig hepatocytes to study the nature of protein-bound metabolites of furazolidone. Food and Chem/Cal Toxicity, 29, 321–328.
- HOOGENBOOM, L. A. P., BERGHMANS, M. C. J., POLMAN, T. H. G., PARKER, R. and SHAW, I. C., 1992, Depletion of protein-bound furazolidone metabolites containing the 3-amino-2-oxazolidinone side chain from liver, kidney, and muscle tissue from pigs. Food Additives and Contaminants, 9, 623–630.
- HORNE, E., CADOGAN, A., O'KEEFE, M. and HOOGENBOOM, L. A. P., 1996, Analysis of protein-bound metabolites of furazolidone and furaltadone in pig liver by high-performance liquid chromato-graphy with UV and mass spectrometric detection. Proceedings of the EuroResidue III Conference, 1,510–515.
- KLEE, S., UNGEMACH, F. R. and KROKE R., 1992, Fate of furazolidone in the isolated perfused gut and in isolated intestinal cells. Acta V eterinaria Scandinavica, 87 (suppl.), 452–453.
- KLUGE, K., KLEE, S. and UNGEMACH, F. R., 1996, Studies on the covalent binding of furazolidone to liver microsomes. Naunyn Schmiedeberg's Archives of Pharmacology, 253 (suppl.), R10.
- LOWRY, 0. H., ROSEBROUGH, N. J., FARR, A. and RANDALL, R. J., 1951, Protein measurements with the Folin reagent. Journal of Biological Chemistry, 193, 265–275.
- MEUNIER, V., BOURRIE, M., BERGER, Y. and FABRE, G., 1995, The human intestinal epithelial cell line Caco-2; pharmacological and pharmacokinetic applications. Cell Biology and Toxicology, 11, 187–194.
- PAUL, H. E. and PAUL, M. F., 1964, The nitrofurans — chemotherapeutic properties. In R. J. Schnitzer and F. Hawking (eds), Experimental Chemotherapy, vol. 2 (New York: Academic Press), pp. 307–370.
- PINTO, M., ROBINE -LEON, S., APPAY, M. D., KEDINGER, M., TRIADOU, N., DUSSAULX, E., LACROIX, B., SuvioN -ASSMAN, P., HAFFEN, K., FOGH, J. and ZWEIBAUM, A., 1983, Enterocyte-like differentiation and polarisation of the human colon carcinoma cell line Caco-2 in culture. Biology of the Cell, 47, 323–330.
- RANALDI, G., ISLAM, K. and SAMBU Y., 1992, Epithelial cells in culture as a model for the intestinal transport of antimicrobial agents. Antimicrobial Agents and Chemotherapy, 36, 1374–1381.
- RICHTER, E. and STRUGALA, G. J., 1985, An all-glass perfusator for investigation of the intestinal transport and metabolism of foreign compounds in vitro. Journal of Pharmacological Methods, 14, 297–304.
- RICO, A. G. and BURGAT-SACAZE, V., 1984, Toxicological significance of covalently bound residues. Food Additives and Contaminants, 1, 157–161.
- TATSUMI, K., NAKABEPPU H., TAKAHASHI, S. and KITAMURA, S., 1984, Metabolism in vivo of furazolidone: evidence for formation of an open-chain carboxylic acid and ketoglutaric acid from the nitrofuran in rats. Archives of Biochemistry and Biophysics, 234, 112–116.
- VilAm, A., 1990, Definition of bound residues. Drug Metabolism Reviews, 22, 591–593.
- VROOMEN, L. H. M., BERGHMANS, M. C. J., VAN LEEUWEN, P., VAN DER STRUIJS, T. D. B., DE VRIES, P. H. U. and KUIPER, H. A., 1986, Kinetics of ' C-furazolidone in piglets upon oral administration during 10 days and its interaction with tissue macromolecules. Food Additives and Contaminants, 3, 331–346.
- VROOMEN, L. H. M., BERGHMANS, M. C. J., HEKMAN, P., HOOGENBOOM, L. A. P. and KUIPER, H. A., 1987a, The elimination of furazolidone and its open-chain cyanoderivative from adult swine. Xenobiotka, 17, 1427–1435.
- VROOMEN, L. H. M., GROTEN J. P., VAN MUISWINKEL, K., VAN VELDHUIZEN, A. and VAN BLADEREN P. J., 1987b, Identification of a reactive intermediate of furazolidone formed by swine liver microsomes. Toxicology In vitro, 1, 97–104.
- VROOMEN, L. H. M., BERGHMANS, M. C. J., VAN BLADEREN, P. J., GROTEN J. P., WISSINK, C. J. and KUIPER, H. A., 1990, In vivo and in vitro metabolic studies of furazolidone: a risk evaluation. Drug Metabolism Reviews, 22, 663–676.
- WEBER, N. E., 1992, Bound residues — safety testing and risk assessment. In H. A. Kuiper and L. A. P. Hoogenboom (eds), Proceedings of the Workshops, Ghent, 22–24 May 1992 and Thessaloniki, 30–31 October 1992 (Wageningen: State Institute for Quality Control of Agricultural Products (RIKILT-DLO)).
- WENTGES H., KLEE, S., UNGEMACH, F. R. and POSPISCHIL, A., 1991, Influence of different solvents on the functionality and viability of the isolated perfused gut. Naunyn-Schmiedeberg's Archives of Pharmacology, 344 (suppl.), 33.